节点文献

资产贝塔法在企业贝塔值估计中的应用——从哈药股份案例看历史回归法的局限

Estimating Firm Beta Using Asset-Beta Method——A Case Study of Harbin Pharmaceutical Group Illustrating the Limitations of Regression Methods Based on Historical Stock Returns

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 张矢的吴斌王晓雯

【Author】 Zhang Shidi1, Wu Bin1 and Wang Xiaowen2 (1. Management School, Graduate University of Chinese Academy of Science, Beijing 100190; 2. Investment Banking Department of CITIC,Beijing 100004)

【机构】 中国科学院研究生院管理学院中信证券投资银行部

【摘要】 本文以南方证券2000-2003年间对哈药集团股份有限公司(哈药股份)股票的操纵案例为切入点,通过历史回归法逐月计算了1998-2007年间该公司的贝塔系数时间序列,揭示了采用历史回归法估计企业贝塔系数的局限;并引入和运用资产贝塔法对哈药股份的贝塔系数进行了重新估计。通过对比分析,得到了资产贝塔法可以更为客观、准确的估计企业贝塔系数的结论。本文认为,资产贝塔法在中国的引入和应用,对估计企业的股权成本、资本成本、以及企业的作价和业绩评价均有重要的意义。

【Abstract】 This paper draws on the case of the illegal stock price manipulation of Harbin Pharmaceutical Group (HPG) in the Chinese A share market by China Southern Securities during the 2000-2003 period; and by observing changes in the beta estimations of HPG obtained by the regression method month by month for the period of 1998-2007, it illustrates the limitation of the regression method. The paper then utilizes what is called asset-beta method to recalculate the beta of HPG during the same period. The results of the comparative analysis demonstrate that the asset-beta method can yield a more objective and accurate estimation of HPG’s beta coefficient. The paper concludes that the introduction and application of asset-beta method in China has important implications in estimating costs of equity and capital, firm valuation and performance evaluation.

  • 【分类号】F275
  • 【被引频次】15
  • 【下载频次】1245
节点文献中: 

本文链接的文献网络图示:

本文的引文网络